A quantitative systems pharmacological approach identified activation of JNK signaling pathway as a promising treatment strategy for refractory HER2 positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s10928-020-09732-x
Published Online: 2021-01-03
Published Print: 2021-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Franco, Yesenia L.
Ramakrishnan, Vidya
Vaidya, Tanaya R.
Mody, Hardik
Perez, Luis
Ait-Oudhia, Sihem http://orcid.org/0000-0001-8152-3150
Text and Data Mining valid from 2021-01-03
Version of Record valid from 2021-01-03
Article History
Received: 4 September 2020
Accepted: 8 December 2020
First Online: 3 January 2021